Company Description
Vascular Solutions helps answer the age-old question, "How do you mend a broken heart?" The company develops and markets proprietary blood-clotting...
Key Vascular Solutions Financials
| Company Type | Public - NASDAQ (GM): VASC Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $52.9 |
| 2007 Employees | 242 |
More Vascular Solutions Financials (11 pages)
Latest Vascular Solutions Jobs jobs by Indeed
Competition
Competitive Landscape for Medical Supplies and Devices
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior...
Read more about Vascular Solutions's competition across multiple industries
Top Vascular Solutions Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Vascular Solutions Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| CEO and Director | Howard C. Root | Network | E-mail |
| VP Finance, CFO, and Secretary | James Hennen | Network | E-mail |
| VP Marketing | Fred Reuning | Network | E-mail |
More Vascular Solutions Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Vascular Solutions News
- Vascular Solutions, Inc. (VASC) Corporate Event Announcement Notice [Wall Street Horizon] (03 Jul 2008 21:17:00 EDT)
- [MDW]-Court report: VNUS launches suits vs. Dornier, Biolitec, NewStar [AHC Newsletters] (03 Jul 2008 00:01:00 EDT)
- Vascular Solutions, Inc. (VASC) Corporate Event Announcement Notice [Wall Street Horizon] (20 Jun 2008 21:04:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.